Pediatrix Medical Group, Inc. (MD) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $246.86M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.41× | Operating cash flow / net income. Period ending 2026-06-30. $246.86M ÷ $174.81M ≈ 1.41× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 246.86M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | (m) | |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Revenue | (m) | |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 174.81M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $246.86M | (m) | (m) | (m) | (m) | $174.81M | (m) | (m) | (m) | 1.41× |
| 2026-03-31 | (m) | (m) | $258.71M | (m) | (m) | (m) | (m) | $174.22M | (m) | (m) | (m) | 1.48× |
| 2025-12-31 | (m) | (m) | $271.09M | (m) | (m) | (m) | (m) | $165.39M | (m) | (m) | (m) | 1.64× |
| 2025-09-30 | (m) | (m) | $290.00M | (m) | (m) | (m) | (m) | $162.19M | (m) | (m) | (m) | 1.79× |
| 2025-06-30 | (m) | (m) | $244.55M | (m) | (m) | (m) | (m) | $109.92M | (m) | (m) | (m) | 2.22× |
| 2025-03-31 | (m) | (m) | $214.34M | (m) | (m) | (m) | (m) | $-82.37M | (m) | (m) | (m) | -2.60× |
| 2024-12-31 | (m) | (m) | $206.57M | (m) | (m) | (m) | (m) | $-99.07M | (m) | (m) | (m) | -2.09× |
| 2024-09-30 | (m) | (m) | $142.81M | (m) | (m) | (m) | (m) | $-253.84M | (m) | (m) | (m) | -0.56× |
| 2024-06-30 | (m) | (m) | $130.91M | (m) | (m) | (m) | (m) | $-251.89M | (m) | (m) | (m) | -0.52× |
| 2024-03-31 | (m) | (m) | $113.02M | (m) | (m) | (m) | (m) | $-70.58M | (m) | (m) | (m) | -1.60× |
| 2023-12-31 | (m) | (m) | $137.32M | (m) | (m) | (m) | (m) | $-60.41M | (m) | (m) | (m) | -2.27× |
| 2023-09-30 | (m) | (m) | $166.76M | (m) | (m) | (m) | (m) | $93.54M | (m) | (m) | (m) | 1.78× |
| 2023-06-30 | (m) | (m) | $170.15M | (m) | (m) | (m) | (m) | $102.88M | (m) | (m) | (m) | 1.65× |
| 2023-03-31 | (m) | (m) | $163.51M | (m) | (m) | (m) | (m) | $101.73M | (m) | (m) | (m) | 1.61× |
| 2022-12-31 | (m) | (m) | $166.94M | (m) | (m) | (m) | (m) | $66.33M | (m) | (m) | (m) | 2.52× |
| 2022-09-30 | (m) | (m) | $112.49M | (m) | (m) | (m) | (m) | $84.19M | (m) | (m) | (m) | 1.34× |
| 2022-06-30 | (m) | (m) | $90.26M | (m) | (m) | (m) | (m) | $84.26M | (m) | (m) | (m) | 1.07× |
| 2022-03-31 | (m) | (m) | $61.44M | (m) | (m) | (m) | (m) | $92.13M | (m) | (m) | (m) | 0.67× |
| 2021-12-31 | (m) | (m) | $76.74M | (m) | (m) | (m) | (m) | $130.96M | (m) | (m) | (m) | 0.59× |
| 2021-09-30 | (m) | (m) | $20.64M | (m) | (m) | (m) | (m) | $19.15M | (m) | (m) | (m) | 1.08× |
| 2021-06-30 | (m) | (m) | $129.47M | (m) | (m) | (m) | (m) | $-52.69M | (m) | (m) | (m) | -2.46× |
| 2021-03-31 | (m) | (m) | $264.32M | (m) | (m) | (m) | (m) | $-760.13M | (m) | (m) | (m) | -0.35× |
| 2020-12-31 | (m) | (m) | $204.62M | (m) | (m) | (m) | (m) | $-796.49M | (m) | (m) | (m) | -0.26× |
| 2020-09-30 | (m) | (m) | $340.71M | (m) | (m) | (m) | (m) | $-722.86M | (m) | (m) | (m) | -0.47× |
| 2020-06-30 | (m) | (m) | $329.97M | (m) | (m) | (m) | (m) | $-1.94B | (m) | (m) | (m) | -0.17× |
| 2020-03-31 | (m) | (m) | $257.02M | (m) | (m) | (m) | (m) | $-1.27B | (m) | (m) | (m) | -0.20× |
| 2019-12-31 | (m) | (m) | $346.64M | (m) | (m) | (m) | (m) | $-1.50B | (m) | (m) | (m) | -0.23× |
| 2019-09-30 | (m) | (m) | $346.61M | (m) | (m) | (m) | (m) | $-1.45B | (m) | (m) | (m) | -0.24× |
| 2019-06-30 | (m) | (m) | $331.16M | (m) | (m) | (m) | (m) | $-125.33M | (m) | (m) | (m) | -2.64× |
| 2019-03-31 | (m) | (m) | $346.74M | (m) | (m) | (m) | (m) | $-37.67M | (m) | (m) | (m) | -9.20× |
| 2018-12-31 | (m) | (m) | $289.93M | (m) | (m) | (m) | (m) | $268.63M | (m) | (m) | (m) | 1.08× |
| 2018-09-30 | (m) | (m) | $357.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $417.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | $419.51M | (m) | (m) | (m) | (m) | $329.11M | (m) | (m) | (m) | 1.27× |
| 2017-12-31 | (m) | (m) | $511.38M | (m) | (m) | (m) | (m) | $320.37M | (m) | (m) | (m) | 1.60× |
| 2017-09-30 | (m) | (m) | $446.69M | (m) | (m) | (m) | (m) | $262.35M | (m) | (m) | (m) | 1.70× |
| 2017-06-30 | (m) | (m) | $442.89M | (m) | (m) | (m) | (m) | $292.98M | (m) | (m) | (m) | 1.51× |
| 2016-12-31 | (m) | (m) | $443.78M | (m) | (m) | (m) | (m) | $324.91M | (m) | (m) | (m) | 1.37× |
| 2013-12-31 | (m) | (m) | $405.40M | (m) | (m) | (m) | (m) | $280.52M | (m) | (m) | (m) | 1.45× |
| 2013-09-30 | (m) | (m) | $372.74M | (m) | (m) | (m) | (m) | $267.65M | (m) | (m) | (m) | 1.39× |
| 2013-06-30 | (m) | (m) | $349.51M | (m) | (m) | (m) | (m) | $256.60M | (m) | (m) | (m) | 1.36× |
| 2013-03-31 | (m) | (m) | $339.42M | (m) | (m) | (m) | (m) | $247.92M | (m) | (m) | (m) | 1.37× |
| 2012-12-31 | (m) | (m) | $325.69M | (m) | (m) | (m) | (m) | $240.91M | (m) | (m) | (m) | 1.35× |
| 2012-09-30 | (m) | (m) | $309.83M | (m) | (m) | (m) | (m) | $233.16M | (m) | (m) | (m) | 1.33× |
| 2012-06-30 | (m) | (m) | $275.21M | (m) | (m) | (m) | (m) | $225.49M | (m) | (m) | (m) | 1.22× |
| 2012-03-31 | (m) | (m) | $253.36M | (m) | (m) | (m) | (m) | $220.89M | (m) | (m) | (m) | 1.15× |
| 2011-12-31 | (m) | (m) | $271.02M | (m) | (m) | (m) | (m) | $218.00M | (m) | (m) | (m) | 1.24× |
| 2011-09-30 | (m) | (m) | $266.00M | (m) | (m) | (m) | (m) | $213.44M | (m) | (m) | (m) | 1.25× |
| 2011-06-30 | (m) | (m) | $271.31M | (m) | (m) | (m) | (m) | $216.47M | (m) | (m) | (m) | 1.25× |
| 2011-03-31 | (m) | (m) | $267.70M | (m) | (m) | (m) | (m) | $209.88M | (m) | (m) | (m) | 1.28× |
| 2010-12-31 | (m) | (m) | $240.56M | (m) | (m) | (m) | (m) | $202.69M | (m) | (m) | (m) | 1.19× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $241.37M | (m) | (m) | (m) | (m) | $175.80M | (m) | (m) | (m) | 1.37× |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $181.39M | (m) | (m) | (m) | (m) | $169.20M | (m) | (m) | (m) | 1.07× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |